French pharmaceutical group Servier has suffered a major setback just four months after completing its $1.55 billion upfront acquisition of Edgewise Therapeutics' muscular dystrophy business.
As advanced therapies and vaccines reshape healthcare, Wacker Biotech is emerging as a CDMO partner of choice. With decades ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results